OSE Immunotherapeutics Unveils Strategic Plan for 2026 - 2028
OSE Immunotherapeutics has revealed its strategic plan for the period 2026 - 2028, focusing on four value creation levers, with an emphasis on the development o…
Follow today's market news in real time: CAC 40 prices, corporate announcements, financial releases and market information. This page automatically aggregates the latest briefs and press releases to give you the most up-to-date view of the moves driving the session.
OSE Immunotherapeutics has revealed its strategic plan for the period 2026 - 2028, focusing on four value creation levers, with an emphasis on the development o…
Renault Group and Ford announce a strategic partnership focused on the development of electric vehicles for the European market, according to a statement from b…
Nexans shares closed on Wednesday, December 10, at 127.70 euros, marking a significant rebound of 3.57% from the previous day, following a sharp decline on Mond…
The shares of the IT services specialist closed the session on Wednesday, December 10, at 49.04 euros, up 1.63% from the previous day. This increase is part of …
French autonomous robotics and navigation systems specialist Exail Technologies fell 2.11% to 88 euros at the close of Wednesday, December 10, after reaching 89…
The stock of the French construction and concessions giant closed sharply lower this Wednesday, December 10, at 116.60 euros, down 3.12% from the previous day. …
The biopharmaceutical company's stock closed at 27.50 euros this Wednesday, December 10, continuing its upward trend that began earlier in the week. This increa…
Nanobiotix shares closed up 5.23% on Wednesday, December 10, following a target price raise by Leerink Partners from $24 to $26 on its American listing, maintai…
Shares of the Nantes-based biotechnology company OSE Immunotherapeutics rose by 4.81% on Wednesday to close at 5.01 euros, buoyed by the presentation of a three…
Métropole TV (M6) shares underwent a significant correction this Wednesday, December 10, 2025, closing at 11.66 euros, down 4.74% from the previous day. This do…
Abivax stock closed on Wednesday, December 10, at 115 euros on Euronext Paris, marking a 9.52% increase from the previous day, amid rumors of potential interest…
The Paris market closed with a slight decline on Wednesday, December 10, 2025, with the CAC 40 slipping 0.37% amid anticipation ahead of the US Federal Reserve'…
Cellectis, a French biotechnology company, has seen a significant increase in its share price, driven by promising clinical trial results and strong technical i…
Ekinops shares saw a significant increase midday on Wednesday, December 10, 2025, following a successful optical transmission test with Orange.
DISCLAIMER: This information is not contractual in nature and carries no guarantee of accuracy. It should not be considered investment advice. Ideal-investisseur.fr cannot be held liable for any damages or losses arising from the use of this information.
